StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Non-GAAP Operating Income by Quarter

Non-GAAP Operating Income ($M)

Teva Pharmaceutical Industries Non-GAAP Operating Income: $1,393M in Q3 2026, up 7.7% from a year earlier.

Latest, Q3 2026
1,393
Period ended Sep 30, 2026
Change on a year earlier
+7.7%
1,294 in Q3 2025
History
33 quarters
Since Q3 2018
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Non-GAAP operating income (loss) | $ | 1,393 | 1,294 | $ | 2,724 | 3,373”

Source: Form 8-K Earnings Release (0001171843-26-007054) ↗

Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Operating Income ($M)Year on yearSource
Q3 2026Sep 30, 20261,393+7.7%Form 8-K Earnings Release (0001171843-26-007054) ↗
Q2 2026Jun 30, 20263750.0%Form 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2026Mar 31, 2026956+1.1%Form 8-K Earnings Release (0001171843-26-002796) ↗
Q4 2025Dec 31, 20254,905+13.3%Form 8-K Earnings Release (0001171843-26-000462) ↗
Q3 2025Sep 30, 20251,294+6.6%Form 8-K Earnings Release (0001171843-25-007000) ↗
Q2 2025Jun 30, 2025375-64.5%Form 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2025Mar 31, 2025946+6.1%Form 8-K Earnings Release (0001171843-25-002849) ↗
Q4 2024Dec 31, 20244,329-0.7%Form 8-K Earnings Release (0001171843-25-000493) ↗
Q3 2024Sep 30, 20241,214+19.0%Form 8-K Earnings Release (0001171843-24-006034) ↗
Q2 2024Jun 30, 20241,056+4.5%Form 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2024Mar 31, 2024892+13.6%Form 8-K Earnings Release (0001193125-24-133759) ↗
Q4 2023Dec 31, 20234,361+5.4%Form 8-K Earnings Release (0001157523-24-000137) ↗
Q3 2023Sep 30, 20231,020+4.4%Form 8-K Earnings Release (0001157523-23-001677) ↗
Q2 2023Jun 30, 20231,011-0.8%Form 8-K Earnings Release (0001157523-23-001212) ↗
Q1 2023Mar 31, 2023785-22.5%Form 8-K Earnings Release (0001157523-23-000797) ↗
Q4 2022Dec 31, 20224,139-6.0%Form 8-K Earnings Release (0001157523-23-000205) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Non-GAAP Operating Income ($M), quarterly Q3 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-op-inc

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?